Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
Just over thirteen months ago, PeaceHealth announced the closure of their University District Hospital in Eugene, the fallout ...
The majority of cuts will take place in December, according to a notice filed with the state of New Jersey this month.
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
The US Federal Trade Commission said that CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum ...
Optum is the parent company of Deerfield, Ill.-based ASC chain SCA Health, which has a portfolio of more than 320 ASCs and 9,200 physicians. Here are five things to know about Optum's recent moves: ...
OptumCare, headquartered in Basking Ridge, N.J., is planning to lay off 160 employees, as indicated by a WARN notice posted on the New Jersey Department of Labor and Workforce Development website.
The FTC accuses the largest pharmacy benefit manager companies of unfairly boosting prices on prescription drugs.
The Federal Trade Commission is suing the three largest prescription drug benefit managers (PBMs) for allegedly driving up ...
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...
At a summit Tuesday, top industry minds discussed how they are working to bridge the gap between medical and behavioral ...
Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback